IHS Chemical Week

Regions :: North Asia :: Japan

Dr. Reddy's and Fujifilm call off JV for generic drugs in Japan, to explore opportunities in APIs

7:59 AM MDT | June 3, 2013 | Deepti Ramesh

Dr. Reddy’s Laboratories (Hyderabad, India) and Fujifilm (Tokyo) have decided to terminate their previously announced agreement for an exclusive partnership in the generic drugs business in the Japanese market via a joint venture in Japan, the companies announced today. Dr. Reddy’s and Fujifilm signed an memorandum of understanding (MOU) in July 2011 to establish a jv in Japan for manufacturing finished generic drugs for the Japanese market. It was agreed that Fujifilm would hold a 51% stake in the jv, and Dr. Reddy’s would hold the rest. The...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa